ClinicalTrials.gg
CompletedNCT03280225REACH VETUpdated Jan 25, 2024Results posted

REACH VET Implementation Program Evaluation

An observational study in Suicide, sponsored by VA Office of Research and Development. Completed at 2 sites in United States. Per ClinicalTrials.gov, last updated 2024-01-25.

Sponsored by VA Office of Research and Development · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
28
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 43 studies in Suicide by VA Office of Research and Development — 15 open to participants now, 16 under way, none of them phase 3. Suicide · VA Office of Research and Development.

Started
2017
with 1 other
Observational
2 of 43
none open now
Registered
10th of 43
by date

Among the 43 studies in Suicide by VA Office of Research and Development, this one is one of 2 that started in 2017, is one of 2 observational ones, and was the 10th registered.

By phase

43 studies; the count open now beside each. This study's row is marked.

No phase35 · 11 open
Observationalthis study2 · 0 open
Phase 12 · 1 open
Phase 22 · 2 open
Phase 1/21 · 1 open
Phase 2/31 · 0 open

By the year they started

First in 2013; this study’s year is marked. 2 started in 2017.

What they test

Size and results

Median enrollment 104 across the 41 interventional studies, 28 across the 2 observational. Of the 27 that completed or were terminated, 24 (89%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 43 studies in Suicide by VA Office of Research and Development, or all of them as a file.
02

Study summary

The VA's Office of Mental Health and Suicide Prevention implemented an new program to increase suicide prevention outreach for Veterans at highest risk for suicide. Using a statistical model, REACH VET, short for Recovery Engagement and Coordination for Health - Veterans Enhanced Treatment, uses information from Veterans' health records to identify those who are at a higher risk for suicide, hospitalization, illness, or other negative outcomes. Once a Veteran is identified, his or her VA mental health or primary care provider reaches out to check on the Veteran's well-being and review their treatment plan to determine if enhanced care is needed. The goal of the current study was to evaluate the implementation of this program. The objectives of this evaluation were to evaluate how well this program is put into place using an implementation strategy called virtual external facilitation, and to collect data about the cost of the program and the strategy.

Read the detailed description

The VA's Office of Mental Health and Suicide Prevention is implemented an innovative new program to increase suicide prevention outreach and target Veterans at highest risk for suicide. Using a new predictive model, REACH VET, short for Recovery Engagement and Coordination for Health - Veterans Enhanced Treatment, analyzes existing data from Veterans' health records to identify those who are at a statistically elevated risk for suicide, hospitalization, illness, or other adverse outcomes. Once a Veteran is identified, their VA mental health or primary care provider reaches out to check on the Veteran's well-being and review their condition(s) and treatment plans to determine if enhanced care is needed.

The goal of the proposed study is to evaluate the implementation of REACH VET. The objectives of this evaluation are to:

  1. evaluate the implementation of REACH VET using virtual external facilitation, and
  2. collect preliminary data about the cost and cost offsets.

The current evaluation will examine the impact of a virtual external facilitation strategy on the implementation of REACH VET in 28 medical facilities across 7 Veteran Integrated Service Networks (VISNs) in a stepped wedge design. Primary implementation outcomes include metrics of REACH VET implementation: coordinator assignment, provider assignment, care evaluation, and attempted outreach. Qualitative interviews will be conducted with implementation facilitators, Suicide Prevention Coordinator(s), clinical leadership, and providers to identify barriers and facilitators to implementation of REACH VET and the experience of facilitation. Secondary data will be collected on the cost of the intervention and the cost of implementation strategy.

03

Conditions studied

  • Suicide

Browse trials for

Keywords

  • Suicide
  • Prevention
  • Implementation
  • Facilitation
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will include facilities receiving virtual external facilitation for REACH VET

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • VA employee at a facility receiving virtual external facilitation
  • Involved in REACH VET implementation

Exclusion criteria

Exclusion Criteria:

  • Not a VA employee
  • Not employed at a facility receiving virtual external facilitation
  • Not involved in REACH VET implementation
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
28 participants (actual)
Patient registry
No
Biospecimen retention
None retained

Groups and cohorts

  • VAMC's receiving implementation support for REACH VET

    This cohort consists of 28 VA Medical Centers (VAMC's) needing additional implementation support to fully implement REACH VET as identified by Veteran Integrated Service Network (VISN) leadership, and that agreed to participate.

    Other: External facilitation

Interventions

  • OtherExternal facilitation

    Facilitation is an evidence-based implementation strategy to support sites that have difficulty implementing innovative programs. Facilitation is a multi-faceted "process of interactive problem solving and support that occurs in the context of a recognized need for improvement and a supportive interpersonal relationship (Powell et al., 2015)." Facilitation has been used nationally across VA to implement a number of different clinical interventions. The current project will examine this minimally intensive version of implementation facilitation, virtual external facilitation.

    Also known as: Virtual external facilitation, facilitation, implementation facilitation

06

What researchers measure

Primary outcomes

  1. Coordinator Assigned Post-Implementation

    The average percentage of eligible Veterans across all 23 participating sites having a coordinator assigned within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period.

    Time frame: 6 months after implementation was completed

  2. Provider Assigned Post-Implementation

    The average percentage of eligible Veterans across all 23 participating sites having a provider assigned within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period .

    Time frame: 6 month period following implementation

  3. Care Evaluation Performed Post-Implementation

    The average percentage of eligible Veterans across all 23 participating sites receiving a care evaluation within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period.

    Time frame: 6 month period following implementation

  4. Attempted Outreach Post-Implementation

    The average percentage of eligible Veterans across all 23 participating sites where outreach was attempted within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period.

    Time frame: 6 month period following implementation

Secondary outcomes

  1. Organizational Readiness for Change Survey

    Eligible staff at participating VA facilities were solicited to complete a modified version of the Texas Christian University Organizational Readiness for Change - Staff (TCU ORC-S). We abbreviated the original instrument to 62 items and modified text for contextual relevance. Responses were collected from 22 sites across five Veteran Integrated Service Networks (VISN). The responses were scored on ten scales: Program Needs (10 - 50 higher is preferred), Training Needs (10 - 50 higher is preferred), Pressure for Change (10 - 50 higher is preferred), Staffing (10 - 50 higher is preferred), Mission (10 - 50 higher is preferred), Cohesion (10 - 50 higher is preferred), Autonomy (10 - 50 higher is preferred), Communication (10 - 50 higher is preferred), Stress (10 - 50 lower is preferred) and Change (10 - 50 lower is preferred).

    Time frame: 1 month

07

Results

Posted Jan 25, 2024

Participant flow

VA Medical Centers in five Veteran Integrated Service Networks were identified by leadership as needing additional support in or der to implement REACH VET.

Participant flow — Overall Study
MilestoneVAMC's Receiving Implementation Support for REACH VET
StartedNA
CompletedNA
Not completedNA

Outcome measures

PrimaryCoordinator Assigned Post-Implementation

The average percentage of eligible Veterans across all 23 participating sites having a coordinator assigned within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period.

Time frame:
6 months after implementation was completed
Reported as:
Mean · percentage
Coordinator Assigned Post-Implementation
percentageVISNs Requesting Implementation Support
Coordinator Assigned Post-Implementation97.6 ± 1.0
Statistical analysis
  • VISNs Requesting Implementation Support · Regression, Logistic · p = .302 · Odds ratio (or): 1.43 · 95% CI 0.73 to 2.82Odds ratios were estimated using GEE to control for clustering within VAMCs. Fixed effects included a time-dependent variable (pre-post) as well an independent variable of time to account for improvement due to secular trends.
PrimaryProvider Assigned Post-Implementation

The average percentage of eligible Veterans across all 23 participating sites having a provider assigned within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period .

Time frame:
6 month period following implementation
Reported as:
Mean · percent
Provider Assigned Post-Implementation
percentVISNs Requesting Implementation Support
Provider Assigned Post-Implementation87.2 ± 17.3
Statistical analysis
  • VISNs Requesting Implementation Support · Regression, Logistic · p = 0.226 · Odds ratio (or): 1.29 · 95% CI 0.86 to 1.93Odds ratios were estimated using GEE to control for clustering within VAMCs. Fixed effects included a time-dependent variable (pre-post) as well an independent variable of time to account for improvement due to secular trends.
PrimaryCare Evaluation Performed Post-Implementation

The average percentage of eligible Veterans across all 23 participating sites receiving a care evaluation within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period.

Time frame:
6 month period following implementation
Reported as:
Mean · percent
Care Evaluation Performed Post-Implementation
percentVISNs Requesting Implementation Support
Care Evaluation Performed Post-Implementation83.6 ± 18.9
Statistical analysis
  • VISNs Requesting Implementation Support · Regression, Logistic · p = 0.199 · Odds ratio (or): 1.23 · 95% CI 0.90 to 1.70Odds ratios were estimated using GEE to control for clustering within VAMCs. Fixed effects included a time-dependent variable (pre-post) as well an independent variable of time to account for improvement due to secular trends.
PrimaryAttempted Outreach Post-Implementation

The average percentage of eligible Veterans across all 23 participating sites where outreach was attempted within 2 weeks of the monthly REACH VET report being released during the 6 month post-implementation period.

Time frame:
6 month period following implementation
Reported as:
Mean · percent
Attempted Outreach Post-Implementation
percentVISNs Requesting Implementation Support
Attempted Outreach Post-Implementation77.0 ± 20.6
Statistical analysis
  • VISNs Requesting Implementation Support · Regression, Logistic · p = 0.011 · Odds ratio (or): 1.38 · 95% CI 1.08 to 1.76Odds ratios were estimated using GEE to control for clustering within VAMCs. Fixed effects included a time-dependent variable (pre-post) as well an independent variable of time to account for improvement due to secular trends.
SecondaryOrganizational Readiness for Change Survey

Eligible staff at participating VA facilities were solicited to complete a modified version of the Texas Christian University Organizational Readiness for Change - Staff (TCU ORC-S). We abbreviated the original instrument to 62 items and modified text for contextual relevance. Responses were collected from 22 sites across five Veteran Integrated Service Networks (VISN). The responses were scored on ten scales: Program Needs (10 - 50 higher is preferred), Training Needs (10 - 50 higher is preferred), Pressure for Change (10 - 50 higher is preferred), Staffing (10 - 50 higher is preferred), Mission (10 - 50 higher is preferred), Cohesion (10 - 50 higher is preferred), Autonomy (10 - 50 higher is preferred), Communication (10 - 50 higher is preferred), Stress (10 - 50 lower is preferred) and Change (10 - 50 lower is preferred).

Time frame:
1 month
Reported as:
Mean · score on a scale
Organizational Readiness for Change Survey
score on a scaleVISN AVISN BVISN CVISN DVISN E
Program Needs25.77 ± 7.7831.74 ± 7.2732.86 ± 11.4728.96 ± 7.5527.17 ± 10.29
Training Needs21.90 ± 5.2525.94 ± 8.4930.00 ± 13.8425.93 ± 7.3324.78 ± 9.64
Pressure for Change29.91 ± 5.0430.56 ± 6.1630.00 ± 6.8029.29 ± 6.0328.87 ± 8.74
Staffing29.86 ± 6.6128.23 ± 6.6430.00 ± 6.0831.15 ± 6.3726.67 ± 4.84
Mission33.46 ± 6.9431.38 ± 6.9632.29 ± 10.0933.27 ± 6.4830.21 ± 7.45
Cohesion31.67 ± 10.3032.36 ± 8.0035.24 ± 8.5833.75 ± 7.5633.32 ± 8.49
Autonomy34.78 ± 5.7132.47 ± 5.7532.00 ± 7.8335.98 ± 4.8032.24 ± 5.22
Communication31.74 ± 7.2728.18 ± 6.8729.86 ± 6.9930.80 ± 7.2730.32 ± 7.16
Stress33.19 ± 8.1434.63 ± 6.9330.71 ± 11.7931.31 ± 8.1136.97 ± 8.32
Change31.30 ± 5.7429.52 ± 6.3029.71 ± 11.9732.72 ± 5.8231.47 ± 4.63
Statistical analysis
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .018F (4, 158) = 3.08
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .136F (4, 158) = 1.78
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .812F (4, 158) = 0.39
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .358F (4, 158) = 1.10
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .748F (4, 158) = 0.48
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .748F (4, 158) = 0.48
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .005F (4, 158) = 3.88
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .224F (4, 158) = 1.44
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .043F (4, 158) = 2.52
  • VISN A vs VISN B vs VISN C vs VISN D vs VISN E · ANOVA · p = .096F (4, 158) = 2.01

Adverse events

Collected over All-cause mortality, serious and other adverse events were not monitored or assessed for this implementation evaluation by the study team.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
VISNs Requesting Implementation Support———

Baseline characteristics

23 VA Medical Centers participating in implementation of REACH VET, Participants were not assigned to study arms

Age, Continuous
Age, Continuous(VAMC)VISNs Requesting Implementation Support
MeanNA ± NA
Sex: Female, Male
Sex: Female, Male(VAMC)VISNs Requesting Implementation Support
FemaleNA
MaleNA
Race/Ethnicity, Customized
Race/Ethnicity, Customized(VAMC)VISNs Requesting Implementation Support
UnitsNA
Coordinator Accepted Pre-Implementation
Coordinator Accepted Pre-Implementation(percent)VISNs Requesting Implementation Support
Mean88.5 ± 16.7
Provider Assigned Pre-Implementation
Provider Assigned Pre-Implementation(percentage)VISNs Requesting Implementation Support
Mean68.1 ± 25.5
Care Evaluation Performed Pre-Implementation
Care Evaluation Performed Pre-Implementation(percentage)VISNs Requesting Implementation Support
Mean63.4 ± 23.9
Outreach Attempted Pre-Implementation
Outreach Attempted Pre-Implementation(percent)VISNs Requesting Implementation Support
Mean56.2 ± 77.0
08

Study locations

2 sites
  • Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
    North Little Rock, Arkansas 72114-1706, United States
  • VA Eastern Colorado Health Care System, Denver, CO
    Denver, Colorado 80220, United States
09

References and documents

Publications

  • Reger MA, Luxton DD, Tucker R, Comtois KA, Keen AD, Landes SJ, Matarazzo BB, Thompson C. Implementation Methods for the Caring Contacts Suicide Prevention Intervention. Professional Psychology, Research and Practice. 2017 Oct 1; 48(5):369-377.

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2017 to primary completion in Mar 2020, 29 months.

Results were first posted in Jan 2024, 3 years 10 months after primary completion.

Of 35 non-industry observational studies under Suicide, half reached primary completion within 51 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 93. This study's 29 months is below that.

Counting every sponsor, half of 37 studies reached it within 51 months; a quarter within 28 and three quarters within 93.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2017
First posted
Sep 12, 2017
StartActual
Sep 18, 2017
Primary completionActual
Mar 13, 2020
CompletionActual
Dec 31, 2020
Results first posted
Jan 25, 2024
Last update
Jan 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03280225
Responsible party
Sponsor
First posted
Sep 12, 2017
Start date
Sep 18, 2017
Primary completion
Mar 13, 2020
Completion
Dec 31, 2020
Results posted
Jan 25, 2024
Last update
Jan 25, 2024

Study contacts

Sara J. Landes, PhD
principal investigator · Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion